CIK 0001534969
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
SERA PROGNOSTICS, INC.
Sign in to watch- Ticker
- SERA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 261911522
- Phone
- +1 801-990-0520
- Business address
- 2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
- Former names
- SERA PROGNOSTICS, INC.
- 4 Grant or award Director acquired 7,117 shares (grant or award)
- 4 Grant or award Director acquired 7,117 shares (grant or award)
- 4 Grant or award Director acquired 7,117 shares (grant or award)
- 4 Grant or award Director acquired 7,117 shares (grant or award)
- 4 Grant or award Director acquired 7,117 shares (grant or award)
- 4 Grant or award Director acquired 7,117 shares (grant or award)
- 4 Other acquisition Director acquired 208 shares (other)
- 4 Other disposition Director disposed of 930,901 shares (other)
- 4 Open-market sale Chief Data Officer sold 10,387 shares at $8.24 ($85,589)
- 4 Grant or award Chief Data Officer acquired 40,854 shares (grant or award)
- 4 Open-market sale Chief Data Officer sold 4,205 shares at $9.59 ($40,326)
- 4 Open-market sale Chief Scientific Officer sold 4,902 shares at $9.59 ($47,010)
- 4 Open-market sale General Counsel sold 4,902 shares at $9.59 ($47,010)
- 4 Open-market sale Chief Financial Officer sold 6,592 shares at $9.59 ($63,217)
- 4 Open-market sale Chief Executive Officer sold 11,992 shares at $9.59 ($115,003)
- 4 Open-market sale Chief Information Officer sold 4,902 shares at $9.59 ($47,010)
- 4 Planned sale Chief Scientific Officer sold 77,136 shares at an average $9.44 ($727,853)
- 4 Open-market sale Chief Executive Officer sold 38,899 shares at $9.37 ($364,484)
- 4 Open-market sale Chief Financial Officer sold 8,092 shares at $9.37 ($75,822)
- 4 Open-market sale Chief Scientific Officer sold 21,438 shares at $9.55 ($204,733)
Page 10 of 16 · 313 filings